In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus
- 1 August 1984
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 26 (2), 268-269
- https://doi.org/10.1128/aac.26.2.268
Abstract
Flucloxacillin, fosfomycin, fusidic acid, teichomycin, and vancomycin were tested against 50 clinical isolates of methicillin-resistant Staphylococcus aureus by a broth macrodilution technique. Teichomycin had a narrow range of activity, similar to that of vancomycin (0.5 to 2.0 micrograms/ml). Fusidic acid had the lowest range of inhibitory activity, with 50 and 90% MICs of 0.19 and 0.35 micrograms/ml, respectively. Flucloxacillin and fosfomycin showed less activity, with MICs up to 32 micrograms/ml.Keywords
This publication has 19 references indexed in Scilit:
- Variable Tolerance of a Clinical Isolate of Staphylococcus epidermidis from an Infected Hydrocephalus Shunt for Several %beta;-Lactam Antibiotics, Vancomycin and FosfomycinChemotherapy, 1981
- Flucloxacillin in bone.Journal of Clinical Pathology, 1978
- Activity of Fosfomycin in the Treatment of Bacterial InfectionsChemotherapy, 1977
- Fosfomycin in Chronic Urinary InfectionsChemotherapy, 1977
- Bacteriological Evaluation of Fosfomycin in Clinical StudiesChemotherapy, 1977
- Flucloxacillin in the treatment of infectious conditions in childrenCurrent Medical Research and Opinion, 1975
- THE MECHANISM OF ACTION OF FOSFOMYCIN (PHOSPHONOMYCIN)Annals of the New York Academy of Sciences, 1974
- Interpretation of Diffusion Susceptibility Data Obtained with 10-μg Fucidin (Sodium Fusidate) Disks against Clinical Isolates of Staphylococcus aureusChemotherapy, 1974
- Fucidin-Resistant Staphylococci in Current Hospital PracticeJournal of Medical Microbiology, 1973
- FUCIDIN: A New Orally Active AntibioticThe Lancet, 1962